NDAOPHTHALMICSOLUTION/DROPS
Approved
Sep 2006
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20
Mechanism of Action
acid, a prostaglandin analog is a selective FP prostanoid receptor agonist, which is believed to reduce IOP by increasing uveoscleral outflow. The exact mechanism of action is unknown at this time.
Pharmacologic Class:
Prostaglandin Analog
Clinical Trials (5)
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Started Dec 2025
30 enrolled
Open Angle Glaucoma (OAG)Ocular Hypertension (OH)
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Started Jun 2025
610 enrolled
Glaucoma
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension
Started Nov 2023
250 enrolled
Open Angle GlaucomaOcular Hypertension
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
Started Sep 2023
230 enrolled
Glaucoma, Open-Angle
Travoprost Intraocular Implant in Conjunction With Cataract Surgery
Started Sep 2023
60 enrolled
Open Angle GlaucomaOcular Hypertension
Loss of Exclusivity
LOE Date
Oct 13, 2029
43 months away
Patent Expiry
Oct 13, 2029